| Expression pattern: |
DN |
| Associated gene: |
GSTM2 |
| Associated microRNA: |
hsa-miR-744-3p |
| Biological function: |
hsa_circ_0001258 suppressed doxorubicin resistance of osteosarcoma cells and regulated cell viability and IC50 value to doxorubicin. |
| Molecular mechanism: |
ceRNA mechanism: hsa_circ_0001258 sponges hsa-miR-744-3p to upregulate GSTM2 expression. |
| Biological pathway or process: |
ceRNA regulation (other); drug resistance (inhibits); chemoresistance (inhibits) |
| Detected method: |
Q
S
|
| Validation methods: |
RT-qPCR; RNA-seq; Clinical Sample Validation; Bioinformatics Analysis; Transfection; CCK8; Luciferase Reporter Assay; Western Blot |
| Clinical significance: |
Potential novel target for reversing osteosarcoma chemo-resistance; expression validated in chemo-resistant and chemo-sensitive OS tissues. |
| Description: |
hsa_circ_0001258 is down-regulated in chemo-resistant osteosarcoma cell lines and tissues. It suppresses doxorubicin resistance through a ceRNA mechanism by sponging hsa-miR-744-3p and increasing GSTM2 expression. |
| Confidence score: |
0.6676 |